RENALOGIC U&R IS AN MSP SAFE HARBOR AND AN INDUSTRY LEADER; ALTERNATIVE METHODOLOGIES ARE NOT. BACKGROUND Dialysis claims costs are a significant health plan financial exposure, and a profit center for DaVita and Fresenius that control almost 90% of all…
Renalogic, an industry leader in dialysis risk management and cost containment, announced that it has completed its Service Organization Controls 2 (SOC 2) examination under the Statement on Standards for Attestation Engagements No. 18 (AT-C section 205, Examination Engagements) of…
Two Medicare Secondary Payor Act (MSP) decisions came out in the 9th Circuit Court cases last week: DaVita v. Amy’s Kitchen and DaVita v. Virginia Mason. While the two cases were before the court separately, the same panel of judges…
Cost containment alone is no longer the gold standard when it comes to managing risks associated with Chronic Kidney Disease (CKD). It’s better to avoid catastrophic dialysis and CKD claims costs altogether. Now, CareINSIGHTS.ai enables Renalogic to manage cohort risks…
Executive Summary Multiple-of-Medicare (“MoM”) repricing is a popular and common cost containment strategy used by many plans and repricing companies for dialysis claims repricing. Renalogic has intentionally chosen to stay away from MoM methods because of the high risk of…
The first appellate court decision in the DaVita Medicare Secondary Payor Act (“MSPA”) cases has come down. This decision, in DaVita v. Marietta Hospital, came down in DaVita’s favor and is probably taking a lot of people by surprise. The…
The Latest Development in Dialysis Carves in Pacific Northwest Dialysis In recent years the Pacific Northwest has been the venue for repeated disputes between the large dialysis organizations (“LDOs”) Fresenius and DaVita and payors trying to manage very high LDO…
Check your Kidney Profile or GFR Levels Kidney disease is often called the “silent killer.” More than 37 million American adults have Chronic Kidney Disease (CKD), yet 90 percent of people are not aware because they do not have symptoms.…
Many people do not realize that COVID-19 can affect more than a patient’s lungs. As more and more research on the affects of COVID-19 disseminates, we are finding out that the disease also has the potential to cause long term…
Newsweek Magazine ArticleBy: David H. Freedman Before the pandemic, the plan would have seemed like something ripped from a distant dystopian future in which the human race fully surrenders to Big Tech. On the April 10 online document, the logos…
All Rights Reserved 2021
